148 related articles for article (PubMed ID: 15379332)
1. [Effectiveness of flutamide alone or combined with oral contraceptives in the treatment of hirsutism in women].
Devoto E; Aravena L
Rev Med Chil; 2004 Jul; 132(7):845-52. PubMed ID: 15379332
[TBL] [Abstract][Full Text] [Related]
2. Hormonal and clinical effects of GnRH agonist alone, or in combination with a combined oral contraceptive or flutamide in women with severe hirsutism.
De Leo V; Fulghesu AM; la Marca A; Morgante G; Pasqui L; Talluri B; Torricelli M; Caruso A
Gynecol Endocrinol; 2000 Dec; 14(6):411-6. PubMed ID: 11228061
[TBL] [Abstract][Full Text] [Related]
3. Treatment of hirsutism with flutamide and a low-dosage oral contraceptive in polycystic ovarian disease patients.
Ciotta L; Cianci A; Marletta E; Pisana L; Aglianò A; Palumbo G
Fertil Steril; 1994 Dec; 62(6):1129-35. PubMed ID: 7957975
[TBL] [Abstract][Full Text] [Related]
4. Serum prostate specific antigen levels in women with polycystic ovary syndrome and the effect of flutamide+desogestrel/ethinyl estradiol combination.
Bahceci M; Bilge M; Tuzcu A; Tuzcu S; Bahceci S
J Endocrinol Invest; 2004 Apr; 27(4):353-6. PubMed ID: 15233555
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the clinical efficacy and safety of flutamide versus flutamide plus an oral contraceptive in the treatment of hirsutism.
Taner C; Inal M; Başogul O; Onoglu A; Karanfil C; Tinar S; Ispahi C
Gynecol Obstet Invest; 2002; 54(2):105-8. PubMed ID: 12566753
[TBL] [Abstract][Full Text] [Related]
6. Clinical efficacy and safety of low-dose flutamide alone and combined with an oral contraceptive for the treatment of idiopathic hirsutism.
Dodin S; Faure N; Cédrin I; Méchain C; Turcot-Lemay L; Guy J; Lemay A
Clin Endocrinol (Oxf); 1995 Nov; 43(5):575-82. PubMed ID: 8548942
[TBL] [Abstract][Full Text] [Related]
7. Management of hirsutism.
Falsetti L; Gambera A; Platto C; Legrenzi L
Am J Clin Dermatol; 2000; 1(2):89-99. PubMed ID: 11702316
[TBL] [Abstract][Full Text] [Related]
8. Effect of a combination of ethinylestradiol and desogestrel in adolescents with oligomenorrhea and ovarian hyperandrogenism.
Nappi C; Farace MJ; Leone F; Minutolo M; Tommaselli AP; Montemagno U
Eur J Obstet Gynecol Reprod Biol; 1987 Jul; 25(3):209-19. PubMed ID: 2956138
[TBL] [Abstract][Full Text] [Related]
9. Androgen and lipid profiles in adolescents with polycystic ovary syndrome who were treated with two forms of combined oral contraceptives.
Mastorakos G; Koliopoulos C; Creatsas G
Fertil Steril; 2002 May; 77(5):919-27. PubMed ID: 12009344
[TBL] [Abstract][Full Text] [Related]
10. Effects of flutamide on pituitary and adrenal responsiveness to corticotrophin releasing factor (CRF).
De Leo V; la Marca A; Lanzetta D; Cariello PL; D'Antona D; Morgante G
Clin Endocrinol (Oxf); 1998 Jul; 49(1):85-9. PubMed ID: 9797851
[TBL] [Abstract][Full Text] [Related]
11. The use of flutamide in the management of hirsutism.
Marugo M; Bernasconi D; Meozzi M; Del Monte P; Zino V; Primarolo P; Badaracco B
J Endocrinol Invest; 1994 Mar; 17(3):195-9. PubMed ID: 8051342
[TBL] [Abstract][Full Text] [Related]
12. Prolonged treatment of hirsutism with flutamide alone in patients affected by polycystic ovary syndrome.
Pucci E; Genazzani AD; Monzani F; Lippi F; Angelini F; Gargani M; Barletta D; Luisi M; Genazzani AR
Gynecol Endocrinol; 1995 Sep; 9(3):221-8. PubMed ID: 8540292
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the clinical efficacy of flutamide and spironolactone plus ethinyloestradiol/cyproterone acetate in the treatment of hirsutism: a randomised controlled study.
Karakurt F; Sahin I; Güler S; Demirbas B; Culha C; Serter R; Aral Y; Bavbek N
Adv Ther; 2008 Apr; 25(4):321-8. PubMed ID: 18389188
[TBL] [Abstract][Full Text] [Related]
14. Prospective randomized study comparing the long-acting gonadotropin-releasing hormone agonist triptorelin, flutamide, and cyproterone acetate, used in combination with an oral contraceptive, in the treatment of hirsutism.
Pazos F; Escobar-Morreale HF; Balsa J; Sancho JM; Varela C
Fertil Steril; 1999 Jan; 71(1):122-8. PubMed ID: 9935128
[TBL] [Abstract][Full Text] [Related]
15. Ethinylestradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity.
Ibáñez L; de Zegher F
J Clin Endocrinol Metab; 2004 Apr; 89(4):1592-7. PubMed ID: 15070917
[TBL] [Abstract][Full Text] [Related]
16. Changes in androgens during treatment with four low-dose contraceptives.
Coenen CM; Thomas CM; Borm GF; Hollanders JM; Rolland R
Contraception; 1996 Mar; 53(3):171-6. PubMed ID: 8689882
[TBL] [Abstract][Full Text] [Related]
17. [Finasteride and flutamide in the treatment of hirsutism].
Falsetti L; De Fusco D; Rosina B
Minerva Ginecol; 1997 Oct; 49(10):463-8. PubMed ID: 9463180
[TBL] [Abstract][Full Text] [Related]
18. The influence of combined cyproterone acetate-ethinyl oestradiol therapy on serum levels of dehydroepiandrosterone, androstenedione, and testosterone in hirsute women.
Frölich M; Lachinsky N; Moolenaar AJ
Acta Endocrinol (Copenh); 1977 Feb; 84(2):333-42. PubMed ID: 138326
[TBL] [Abstract][Full Text] [Related]
19. The impact of a pure anti-androgen (flutamide) on LH, FSH, androgens and clinical status in idiopathic hirsutism.
Couzinet B; Pholsena M; Young J; Schaison G
Clin Endocrinol (Oxf); 1993 Aug; 39(2):157-62. PubMed ID: 8370128
[TBL] [Abstract][Full Text] [Related]
20. Treatment with flutamide improves hyperinsulinemia in women with idiopathic hirsutism.
Paoletti AM; Cagnacci A; Orrù M; Ajossa S; Guerriero S; Melis GB
Fertil Steril; 1999 Sep; 72(3):448-53. PubMed ID: 10519615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
